Baris Ugur
Baris Ugur, head of medical, Sanofi Vaccines UK and Ireland
HSJ PartnersHow improved management of Respiratory Syncytial Virus in infants can reduce burden on the NHS
This piece was fully funded, initiated and written by Sanofi.
Close menu
- Home
- Ask HSJ
- Sectors
- Topics
- Local
- Comment
- Interactive
- Events
- Jobs
- All Products
- Subscribe
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud